Kazuhito Ohsawa

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Calpis Co., Ltd., Asahi Group Holdings, Ltd.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhito Ohsawa. Retrieved from https://idiyas.com/inventor/kazuhito-ohsawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Sagamihara-shi, Kanagawa, JP (2013)
Sagamihara, JP (2013 - 2015)
Kanagawa, JP (2016)

Company Filing History:

Asahi Group Holdings, Ltd.

patents

Years Active: 2013-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12178839 - Anti-obesity agent, pollakiuria improving agent, and autonomic nervous activity regulator (2024-12-31),

2. 9523109 - Method for enzymatically preparing peptides for use in improvement of brain function (2016-12-20),

3. 9067972 - Skin aging-inhibiting peptide (2015-06-30),

4. 8916524 - Composition for improving brain function and method for improving brain function (2014-12-23),

5. 8895512 - Composition for improving brain function and method for improving brain function (2014-11-25),

6. 8569241 - Composition for improving brain function and method for improving brain function (2013-10-29),

7. 8367614 - Rheumatoid arthritis-preventive agent for oral intake (2013-02-05),

8. 8344101 - Composition for improving brain function and method for improving brain function (2013-01-01),

9. 8343925 - Composition for improving brain function and method for improving brain function (2013-01-01),

10. 8343924 - Composition for improving brain function and method for improving brain function (2013-01-01),

Title: Kazuhito Ohsawa: Innovator in Health-Related Peptides

Introduction

Kazuhito Ohsawa is a prominent inventor based in Sagamihara, Japan. He has made significant contributions to the field of health and nutrition through his innovative inventions. With a total of 10 patents to his name, Ohsawa's work focuses on improving health outcomes through novel peptide formulations.

Latest Patents

Ohsawa's latest patents include an anti-obesity agent, a pollakiuria improving agent, and an autonomic nervous activity regulator. The anti-obesity agent comprises lactononadecapeptide (LNDP), which is designed to provide a novel technique for anti-obesity improvement. Additionally, he has developed methods for enzymatically preparing peptides that enhance brain function, utilizing hydrolyzed milk casein with specific enzymatic catalysts.

Career Highlights

Throughout his career, Ohsawa has worked with notable companies such as Calpis Co., Ltd. and Asahi Group Holdings, Ltd. His experience in these organizations has contributed to his expertise in peptide research and development.

Collaborations

Ohsawa has collaborated with several professionals in his field, including Kohji Ohki and Naoto Uchida. These partnerships have furthered his research and innovation in health-related peptides.

Conclusion

Kazuhito Ohsawa is a distinguished inventor whose work in peptide technology has the potential to significantly impact health and wellness. His innovative approaches to addressing obesity and improving brain function highlight his commitment to advancing scientific knowledge in the field.

Profile summary based on public USPTO records.